Details for New Drug Application (NDA): 214218
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 214218
Tradename: | PEMETREXED DISODIUM |
Applicant: | Hospira |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Pharmacology for NDA: 214218
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Medical Subject Heading (MeSH) Categories for 214218
Suppliers and Packaging for NDA: 214218
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DISODIUM | pemetrexed disodium | SOLUTION;INTRAVENOUS | 214218 | NDA | Hospira, Inc. | 0409-0004 | 0409-0004-04 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0004-04) / 40 mL in 1 VIAL, SINGLE-DOSE |
PEMETREXED DISODIUM | pemetrexed disodium | SOLUTION;INTRAVENOUS | 214218 | NDA | Hospira, Inc. | 0409-0020 | 0409-0020-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0020-02) / 4 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | ||||
Approval Date: | Jun 22, 2022 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 500MG BASE/20ML (EQ 25MG BASE/ML) | ||||
Approval Date: | Jun 22, 2022 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | ||||
Approval Date: | Jun 22, 2022 | TE: | RLD: | Yes |
Complete Access Available with Subscription